VSI: Vitamin Shoppe, Inc. Instablogs

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Wednesday, May 8, 8:22 AM BofA downgrades Vitamin Shoppe (VSI) to Underperform from Neutral and cuts its price target to $40 from $55 after the retailer made downbeat comments regarding same-store sales after earnings Tuesday. Shares are off 1% premarket on top of yesterday's 8.27% drubbing. Comment! [Consumer]
Tuesday, May 7, 1:34 PM Vitamin Shoppe's (VSI -8%) management is taking "a more cautious view on the year" after saying variability in YTD sales performance and weaker than expected sales in April should translate to comps growth in the "low-to-mid single digits." That's a downward revision from previous guidance. Comps growth was 4.5% in Q1, down markedly from 9.6% in Q1 2012 and off by 0.7% sequentially. VSI does note on the call however, that 2012 Q1 comps benefited from "higher whey protein inflation." (PR, transcript) 1 Comment [Consumer, Earnings, On the Move]
Tuesday, May 7, 6:12 AM Vitamin Shoppe (VSI): Q1 EPS of $0.72 beats by $0.03. Revenue of $279.1M misses by $3.61M. (PR) Comment! [Earnings, Breaking News]
Monday, March 25, 4:15 PM Vitamin Shoppe (VSI -2.4%) slips today, despite its earlier announcement that it's opened its first international franchised Vitamin Shoppe store in Panama City, Panama. Comment! [Healthcare, On the Move]
Tuesday, February 26, 12:45 PM Midday top 10 gainers: MNOV +54%. RNIN +45%. CWH +31%. SLCA +22%. ALC +22%. NOAH +16%. GMXR +14%. PRPH +13%. EMITF +13%. FLML +12%.
Midday top 10 losers: FSGI -25%. HSII -20%. VRTB -19%. VSI -18%. TWI -16%. SSP -13%. ENMD -12%. VVUS -12%. VIPS -10%. CHMT -10%. Comment! [On the Move]
Tuesday, February 26, 9:10 AM Premarket gainers: CWH +28%. ALC +22%. ARWR +17%. AXTI +8%. SPRD +7%. AUXL +6%. DCTH +5%.
Losers: TWI -10%. VVUS -7%. VSI -7%. EEQ -5%. 1 Comment [On the Move]
Tuesday, February 26, 6:31 AM Vitamin Shoppe (VSI): Q4 EPS of $0.40 in-line. Revenue of $218.9M misses by $4M. (PR) Comment! [Earnings, Breaking News]
Tuesday, November 6, 2012, 6:26 AM Vitamin Shoppe (VSI): Q3 EPS of $0.54 beats by $0.08. Revenue of $239M (+14.4% Y/Y) beats by $5M. (PR) Comment! [Earnings]
Wednesday, October 17, 2012, 12:11 PM According to a recent study, it appears that taking a multivitamin daily could reduce the risk of cancer. A large clinical trial of nearly 15K older male physicians followed for more than a decade found that those taking a daily multivitamin experienced 8% fewer cancers than the subjects taking dummy pills. Researchers say that it's a statistically significant reduction, and the findings will be presented today at an American Association for Cancer Research conference. Vitamin Shoppe (VSI +1%) and GNC Holdings (GNC +0.3%) both move higher on the report. 3 Comments [Healthcare]
Tuesday, August 7, 2012, 6:19 AM Vitamin Shoppe (VSI): Q2 EPS of $0.55 beats by $0.04. Revenue of $245M (+13.4% Y/Y) beats by $3M. (PR) Comment! [Earnings]
Thursday, May 17, 2012, 11:35 AM Deutsche Bank says it's time to take some profits off the table in Vitamin Shoppe (VSI -3.9%), cutting the shares from Buy to Hold off the recent spike as they see limited near-term catalysts. The firm notes that VSI is trading at a premium multiple to competitor GNC Holdings (GNC -2.9%) and the growing disparity between the two is not justified. Comment! [Healthcare, Consumer, On the Move]
Tuesday, May 8, 2012, 1:55 PM Shares of Vitamin Shoppe (VSI +9.1%) soar after the company beats on both lines of its Q1 report. CEO Tony Truesdale says on a CC (webcast) that the recent FDA warning on DMAA won't have a material impact on earnings, as the company plans to keep products with the supplements on its shelves until the FDA acts. Comment! [On the Move, Consumer]
Tuesday, May 8, 2012, 6:54 AM Vitamin Shoppe (VSI): Q1 EPS of $0.61 beats by $0.04. Revenue of $248M (+14.4% Y/Y) beats by $9M. (PR) Comment! [Earnings]
Monday, April 30, 2012, 10:37 AM Shares of GNC Holdings (GNC -5.6%) and Vitamin Shoppe (VSI -3.3%) slide after the FDA cracks down on companies offering supplements containing the stimulant DMAA. The agency claims the ingredient increases the risk of higher blood pressure and could lead to possible cardiovascular events if overused. Comment! [On the Move, Consumer]
Tuesday, February 28, 2012, 6:46 AM Vitamin Shoppe (VSI): Q4 EPS of $0.38 beats by $0.06. Revenue of $214.9M (+19% Y/Y) beats by $2M. (PR) Comment! [Earnings]
Wednesday, October 26, 2011, 6:48 AM Vitamin Shoppe (VSI): Q3 EPS of $0.08 in-line. Revenue of $209M (+11.5% Y/Y) beats by $1M. (PR) Comment! [Consumer, Earnings, Breaking News]

VSI Vitamin Shoppe, Inc.

VSI

Vitamin Shoppe, Inc.